Guardian Pharmacy Revenue vs. Total Asset
GRDN Stock | 24.15 0.85 3.40% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 1 B | Current Value 957.9 M | Quarterly Volatility 100 M |
For Guardian Pharmacy profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guardian Pharmacy to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guardian Pharmacy Services, utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guardian Pharmacy's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guardian Pharmacy Services, over time as well as its relative position and ranking within its peers.
Guardian |
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Guardian Pharmacy Total Asset vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Guardian Pharmacy's current stock value. Our valuation model uses many indicators to compare Guardian Pharmacy value to that of its competitors to determine the firm's financial worth. Guardian Pharmacy Services, is rated as one of the top companies in revenue category among its peers. It also is one of the top stocks in total asset category among its peers fabricating about 0.26 of Total Asset per Revenue. The ratio of Revenue to Total Asset for Guardian Pharmacy Services, is roughly 3.86 . At this time, Guardian Pharmacy's Total Revenue is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardian Pharmacy's earnings, one of the primary drivers of an investment's value.Guardian Revenue vs. Competition
Guardian Pharmacy Services, is rated as one of the top companies in revenue category among its peers. Market size based on revenue of Medical Care Facilities industry is currently estimated at about 96.8 Billion. Guardian Pharmacy claims roughly 1.05 Billion in revenue contributing just under 2% to all equities under Medical Care Facilities industry.
Guardian Total Asset vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Guardian Pharmacy |
| = | 1.05 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Guardian Pharmacy |
| = | 271.17 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Guardian Total Asset Comparison
Guardian Pharmacy is currently under evaluation in total asset category among its peers.
Guardian Pharmacy Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Guardian Pharmacy, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Guardian Pharmacy will eventually generate negative long term returns. The profitability progress is the general direction of Guardian Pharmacy's change in net profit over the period of time. It can combine multiple indicators of Guardian Pharmacy, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Net Interest Income | -2.9 M | -3 M | |
Operating Income | 40.9 M | 42.9 M | |
Net Income From Continuing Ops | 37.7 M | 40 M | |
Income Before Tax | 37.7 M | 40 M | |
Total Other Income Expense Net | -367 K | -385.4 K | |
Net Income | 23.9 M | 26.3 M |
Guardian Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Guardian Pharmacy. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Guardian Pharmacy position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Guardian Pharmacy's important profitability drivers and their relationship over time.
Revenue vs Net Income | ||
Total Debt vs Total Asset | ||
Revenue vs Cash Flow From Operations | ||
Working Capital vs Total Asset |
Use Guardian Pharmacy in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Guardian Pharmacy Pair Trading
Guardian Pharmacy Services, Pair Trading Analysis
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Guardian Pharmacy position
In addition to having Guardian Pharmacy in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
View All Next | Launch |
Check out Risk vs Return Analysis. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
To fully project Guardian Pharmacy's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Guardian Pharmacy at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Guardian Pharmacy's income statement, its balance sheet, and the statement of cash flows.